fig6

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Figure 6. Non-targeted Metabolomic Analysis of Hepatic Tissues from Control, OXA, and OCordy Mouse Groups. (A) PLS-DA score plot showing distinct clustering among Control, OXA, and OCordy groups; (B and C) Volcano plots of differentially expressed metabolites in OXA-Control (B) and OCordy-OXA (C) comparisons (red: upregulated; blue: downregulated); (D) Venn diagram identifying 197 common differential metabolites between the two comparisons; (E and F) Pie charts illustrating the distribution of metabolite classes in OXA-Control (E) and OCordy-OXA (F) groups. OXA: Oxaliplatin; OCordy: Oxaliplatin plus cordycepin; PLS-DA: partial least squares discriminant analysis.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/